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Abstract: Dipeptide 4 containing two unnatural amino acids, a modified tyrosine and a phenanthridine derivative, was synthesized. Binding of 
the dipeptide to a series of polynucleotides including ct-DNA, poly A - poly U, poly (dAdT)2, poly dG - poly dC and poly (dGdC)2 was investigated 
by thermal denaturation experiments, fluorescence spectroscopy and circular dichroism. Thermal denaturation experiments indicated that 
dipeptide 4 at pH 5.0, when phenanthridine is protonated, stabilizes ds-DNA, whereas it destabilizes ds-RNA. At pH 7.0, when the 
phenanthridine is not protonated, effects of 4 to the polynucleotide melting temperatures are negligible. At pH 5.0, dipeptide 4 stabilized DNA 
double helices, and the changes in the CD spectra suggest different modes of binding to ds-DNA, most likely the intercalation to poly dG- poly 
dC and non-specific binding in grooves of other DNA polynucleotides. At variance to ds-DNA, addition of 4 destabilized ds-RNA against thermal 
denaturation and CD results suggest that addition of 4 probably induced dissociation of ds-RNA into ss-RNA strands due to preferred binding 
to ss-RNA. Thus, 4 is among very rare small molecules that stabilize ds-DNA but destabilize ds-RNA. However, fluorescence titrations with all 
polynucleotides at both pH values gave similar binding affinity (log Ka ≈ 5), indicating nonselective binding. Preliminary photochemical 
experiments suggest that dipeptide 4 reacts in the photochemical reaction, which affects polynucleotides chirality, presumably via quinone 
methide intermediates that alkylate DNA. 
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INTRODUCTION 
EPTIDES have emerged as promising drug candidates,[1] 
although it is generally known that peptides are prone 
to intracellular enzymatic degradation. This problem can be 
circumvented by use of unnatural analogues modified by N-
methylation,[2] cyclic peptides,[3] or oligopeptides containing 
noncanonical amino acids.[4] Thus, peptide based drug 
conjugates have recently been used for targeted delivery of 
toxic warheads to malignant tumor sites.[5] Furthermore, a 
special endeavor has been devoted to the understanding of 
the process of selective recognition of nucleobase sequences 
by oligopeptides leading to gene transcriptions.[6] Moreover, 
peptide based DNA/RNA intercalators have been discovered, 
which have potential to be developed into selective 
anticancer drugs or highly specific diagnostic tools.[7] 
 With the continuing interest in developing DNA/RNA 
targeting molecules I. Piantanida et al. prepared a series of 
phenanthridine derivatives[8] that were covalently linked by 
different alkyl spacers to one nucleobase[9] or to two 
nucleobases.[10] Investigation of noncovalent binding to 
different polynucleotides showed particularly interesting 
properties for phenanthridine derivatives tethered to 
adenine, which selectively recognized poly U.[9] On the 
other hand, incorporation of two nucleobases diminished 
antiproliferative activity.[10] Furthermore, phenanthridine, 
has recently been incorporated into an amino acid 1 
(Scheme 1),[11] which was used in the synthesis of 
oligopeptides targeting nucleic acids.[11,12] In addition to 
non-covalent binding to polynucleotides, numerous 
anticancer drugs base their action on covalent modification 
of DNA, where cross-linking is particularly cytotoxic event 
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leading to the cell death.[13] For example, anticancer 
antibiotic mitomycin exerts its antiproliferative action on 
metabolic formation of a reactive intermediate quinone 
methide (QM) that cross-links DNA.[14] Consequently, QMs 
have been intensively investigated reactive intermediates 
of phenol derivatives,[15] and their biological activity[16] has 
mainly been connected to the reactivity towards 
nucleosides[17] and alkylation of DNA.[18] Furthermore, S. 
Rokita et al. demonstrated reversible alkylation ability of 
QMs leading to "immortalization of QM" by DNA as a 
nucleophile,[19] whereas Freccero et al. reported ability of 
QMs to alkylate G4 regions of DNA.[20] 
 QMs are reactive intermediates that due to short 
lifetimes cannot be stored, they have to be prepared in situ. 
Photochemical methods offer much milder approach to 
QMs then the use of conventional synthetic methods, since 
photons are traceless reagents, and photoinitiated 
reactions allow for spatial and temporal control of the 
process, which is particularly important for biological 
systems.[21] The most common reactions to generate QMs 
in photochemical reactions are photodehydration[22] and 
photodeamination from the suitably substituted 
phenols.[23] An on-going interest is the photochemical 
generation of QMs from suitable precursors, and 
investigation of their biological effects.[24] Recently we 
incorporated QM precursor into tyrosine and showed that 
2 (Scheme 1) remains photochemically reactive when 
incorporated in oligopeptide.[25] Herein we report the 
synthesis of dipeptide 4 (Scheme 1) containing unnatural 
amino acids 1 and 2. The N-terminus contains 
phenanthridine amino acid 1, which is anticipated to bind 
to polynucleotides by noncovalent interactions. On the 
other hand, the C-terminal amino acid is photochemically 
reactive tyrosine derivative 2 that is anticipated to deliver 
QM upon deamination and allow for covalent DNA 
modification. Covalent linking of QM precursors to DNA 
binding units is known to enhance reactivity of QMs with 
DNA.[26] Therefore, we investigated non-covalent binding of 
dipeptide 4 to different polynucleotides, by thermal 
denaturation experiments, fluorescence and CD 
spectroscopy. Understanding supramolecular interaction 
of this dipeptide is important for its potential application in 
DNA fluorescence labeling, or for the rational design of the 
next generation of DNA-targeting molecules. 
 
RESULTS AND DISCUSSION 
Synthesis 
The synthesis of dipeptide 3 was based on the standard 
peptide coupling procedure where the N-site of 1 was 
protected by Boc and the C-terminus of 2 by Bn. The 
carboxylic functional group of 1 was activated by N,N,N′,N′-
tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluoro-
phosphate (HBTU) and 1-hydroxybenzotriazole (HOBT).[27] 
The dipeptide 3 was isolated in moderate yield, and by use 
of HCl/EtOAc it was transformed to triprotonated salt 4 
(Scheme 1). 
Non-covalent Binding to Polynucleotides 
Studied compound was moderately soluble in aqueous 
solution and its UV-Vis spectra (see Figure S1 in the SI) 
corresponded well to previously studied analogues.[11,12]  
 All supramolecular studies were conducted in 
cacodylate buffered aqueous solution at pH 5.0 and 7.0, 
because two different prototropic forms of 4 are 
anticipated. Namely, the pKa value of protonated 
phenanthridine is ≈ 6.0,[9] whereas the pKa values for the 
phenolic OH and the trimethylamine moiety of amino acid 
2 are 8.46 and 11.15, respectively.[23c] Therefore, at pH 7 
compound 4 has 2+ net positive charge, while at pH 5 it has 
3+ net positive charge. Since DNA/RNA is polyanion, such 
difference in charge could have pronounced effect on 
interactions of 4 with DNA/RNA. 
 Since many phenanthridine analogues bind to ds-
DNA or ds-RNA by intercalation (e.g. ethidium bromide),[28] 
resulting in strong stabilization of double helices against 
thermal denaturation,[28,29] we investigated effects of 4 to 
thermal denaturation of ct-DNA (calf thymus-DNA), as well 
+H3N O
OH
O
N(CH3)2+
O
H
N
OR
O
O
x TFA
x TFA
HBTU, HOBT, TEA, CH3CN
NH3C
O
H
N
N
HO
O
NH3C
O
O
OH
N(CH3)2
HCl/EtOAc
-Cl+H3N N
H
O
N
H+
H3C
O
O
OH
NH(CH3)2+Cl-
Cl-
1-Me 3 42NaOH
dioxane/H2O
R = CH3
1 R = H  
Scheme 1. Synthesis of dipeptide 4. 
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as to synthetic AT-DNA sequence poly (dAdT)2, and also 
poly A - poly U as a model for ds-RNA. Results compiled in 
Table 1 show that 4 at pH 5 induced only moderate stabili-
zation effect to ds-DNAs, whereas the destabilization of ds-
RNA was observed (see Figures S3−S5 in the SI) suggesting 
preferential binding of 4 to ss-RNA. At pH 7.0 the stabili-
zation effects (ΔTm) are less pronounced, in agreement with 
a deprotonation of the phenanthridine (pKa ≈ 6.0[9]), de-
monstrating the importance of protonated phenan-
thridinium on the interaction with the polynucleotide. 
 To determine binding constants for the complexes of 
4 with different polynucleotides including ct-DNA, poly A - 
poly U, poly (dAdT)2, poly dG - poly dC, poly (dGdC)2, taking 
Table 1. The ΔTm values (°C)(a) of studied ds- polynucleotides 
upon addition of 4 at pH 5.0 or pH 7.0 (sodium cacodylate 
buffer, I = 0.05 mol dm−3). 
Polynucleotide 
ΔTm / °C 
pH = 5.0 pH = 7.0 
ct-DNA 3.4 0.3 
poly A - poly U −3.3 and −1.1(b) −0.6 and 0.3(b) 
poly (dAdT)2 5.5 1.0 
(a) Error in ΔTm : ± 0.5°C; The melting temperature was determined from 
the inflection point of the dependence of absorbance on 
temperature.[30] r [4] / [polynucleotide] = 0.3. 
(b) Biphasic transitions: the first transition at Tm = 44.3 °C is attributed to 
denaturation of poly A-poly U and the second transition at Tm = 67.1 °C is 
attributed to denaturation of poly AH+-poly AH+ since poly A at pH 5.0 is 
mostly protonated and forms ds-polynucleotide.[31] 
 
     
Figure 1. LEFT: Fluorimetric titration of 4 (c = 2.0×10−6 mol dm−3, λexc = 330 nm) with ct-DNA in cacodylate buffer (I = 0.05 mol 
dm−3, pH = 5.0, at 25 °C); RIGHT: dependence of the fluorescence intensity at 370 nm on the ct-DNA concentration; dots are 
experimental values and the red line is calculated non-linear fit according to the Scatchard model.[32] 
     
Figure 2. LEFT: Fluorimetric titration of 4 (c = 2.0×10−6 mol dm−3, λexc = 330 nm) with poly dG – poly dC in cacodylate buffer (I = 
0.05 mol dm−3, pH = 5.0, at 25 °C); RIGHT: dependence of the fluorescence intensity at 370 nm on the poly dG – poly dC 
concentration; dots are experimental values and the red line is calculated non-linear fit according to the Scatchard model.[32] 
 
 
 
252 A. ERBEN et al.: Dipeptide Containing Phenanthridine and Modified Tyrosine 
 
Croat. Chem. Acta 2019, 92(2), 249–258 DOI: 10.5562/cca3542 
 
 
 
advantage of intrinsic fluorescence of phenanthridine we 
performed fluorescence titrations. Similar to the thermal 
denaturation experiments, the titrations were conducted 
in cacodylate buffered aqueous solutions at two pH values, 
5.0 and 7.0. In all titration experiments addition of ds-
DNA/RNA to the solution of 4 resulted in fluorescence 
quenching. Some representative results obtained by 
fluorescence titrations are shown in Figures 1−4 (for other 
data see Figures S6−S11 in the SI). Processing of the 
titration data by Scatchard analysis[32] yielded binding 
constants (Table 2). It is interesting to note that similar 
values for the binding constants were observed (log Ka ≈5) 
for solutions regardless of the polynucleotide type and the 
solution pH. The fluorescence titration data indicate that 
dipeptide 4 nonselectively binds to polynucleotide chains, 
regardless of DNA or RNA type, with moderate binding 
constants and similar spectral responses. 
 Circular dichroism (CD) spectroscopy is a very 
valuable tool in the binding study of different small 
molecules to chiral macromolecules such as DNA, or 
peptides.[33] In particular, CD titrations can provide 
information on the binding mode of small molecules to 
       
Figure 3. LEFT: Fluorimetric titration of 4 (c = 2.0×10−6 mol dm−3, λexc = 330 nm) with poly (dGdC)2 in cacodylate buffer (I = 0.05 
mol dm−3, pH = 5.0, at 25 °C); RIGHT: dependence of the fluorescence intensity at 370 nm on the poly (dGdC)2 concentration; 
dots are experimental values and the red line is calculated non-linear fit according to the Scatchard model.[32] 
 
     
Figure 4. LEFT: Fluorimetric titration of 4 (c = 2.0×10−6 mol dm−3, λexc = 330 nm) with poly (dAdT)2 in cacodylate buffer (I = 0.05 
mol dm−3, pH = 5.0, at 25 °C); RIGHT: dependence of the fluorescence intensity at 370 nm on the poly (dAdT)2 concentration; 
dots are experimental values and the red line is calculated non-linear fit according to the Scatchard model.[32] 
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polynucleotide, with distinctive spectral differences for 
intercalators and groove binding derivatives.[34,35]  
 Although phenanthridine chromophore is not chiral, 
in compound 4 it is closely connected to the chiral center of 
amino acids, and in agreement with previously studied 
phenanthridine amino acids[11,12] showed positive CD band 
at 250 nm (Figure 5). Detailed comparison of CD spectra 
intensity revealed that phenanthridine amino acid Phen-AA 
(de-Boc 1×2HCl, Scheme 1) had the weakest CD signal, 
whereas addition of glycine (Phen-AA-Gly) or tyrosine (4) 
increased the intensity due to somewhat better chiral 
organization. However, previously studied bis-
phenanthridine or phenanthridine-thymine peptides 
showed bisignate CD spectra[11,12] characterized by 
distinctly coupled positive and negative CD bands 
attributed to the intensive intramolecular aromatic 
stacking interactions. Such a CD coupling was not observed 
for 4, supporting dominant conformation in which the 
phenanthridine and tyrosine aromatic units do not stack 
with each other. Such a loose organization could be 
favorable for interactions of 4 with ds-DNA/RNA, since it 
leaves the phenanthridine unit free for interactions with 
polynucleotide, thus bringing the photoreactive QM 
precursor in the proximity to a DNA/RNA reaction site. 
 The titrations with 4 and different polynucleotides 
were conducted in cacodylate buffer (I = 0.05 mol dm−3) at 
pH 5.0 or 7.0 in the range of concentration ratio 
r[4]/[polynucleotide] = 0.1−0.7. Representative CD spectra 
are shown in Figures 6−8, whereas all CD data can be found 
in the SI (Figures S12−S14). In all cases, the addition of 
compound 4 to the solution of polynucleotide apparently 
decreased the negative CD signal of polynucleotide in the 
range 220−280 nm (Figure 6 and Figures S12−S14 in the SI), 
but this change was attributed to the positive CD signal for 
chiral peptide 4 in the 220−285 nm range, with a maximum 
at 245 nm (dotted black line in Figure 6), thus upon 
correction showing only negligible changes in the CD 
spectra of DNA/RNA. Such a behavior was observed for 
most polynucleotides at both pH values and suggested  
non-specific binding of the peptide in grooves along  
Table 2. Binding constants (log Ka), ratio n [bound compound 4]/[polynucleotide], and ratio of (I/I0)(b), obtained from 
fluorescence titrations of 4 with different polynucleotides.(a) 
 pH = 5.0 pH = 7.0 
logKa I/I0(b) logKa I/I0(b) 
ct-DNA 5.1 0.3 4.9 0.3 
poly A - poly U 5.2 0.4 5.0 0.6 
poly dG - poly dC 5.3 0.2 5.1 0.2 
poly (dGdC)2 5.9 0.2 5.1 0.3 
poly (dAdT)2 5.1 0.3 5.9 0.5 
(a) The titrations were performed in cacodylate buffered aqueous solutions (I = 0.05 mol dm−3) at 25°C. The binding constants (log Ka) were obtained by nonlinear 
regression analysis of fluorescence data according to Scatchard equation.[32] In the fitting procedure n [bound compound 4]/[polynucleotide] was kept 
constant at the value of 0.2, whereas the other parameters were freely adjustable. 
(b) I0 – starting fluorescence intensity of 4; I – fluorescence intensity of 4/polynucleotide complex calculated by Scatchard equation. 
 
 
Figure 5. The CD spectra of Phen-AA (de-Boc 1×2HCl),[12] 
Phen-AA-Gly[12] and 4 normalized for concentration at pH = 
5.0 (buffer Na cacodylate, I = 0.05 M). 
 
 
Figure 6. CD spectra of ct-DNA (c = 3.0×10−5 mol dm−3) in 
cacodylate buffered aqueous solution (I = 0.05 mol dm−3), at 
pH 5.0 in the presence of different ratio r[4]/[ct-DNA]. Note 
the CD spectrum of free 4 (dotted line; conc. corresponding 
to r = 0.7). 
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ds-DNA/RNA with chromophores of 4 poorly oriented in 
respect to the polynucleotide chiral axis (thus no ICD 
bands). 
 However, several peculiar results were obtained. For 
poly dG - poly dC at pH 5 addition of 4 induced a 
pronounced decrease of the band at 289 nm, accompanied 
with a bathochromic shift of 5 nm (Figure 7). It should be 
stressed that this change is not due to the overlapping 
positive CD signal of 4, which should cause increase of the 
CD band instead of the observed decrease. Detailed 
inspection of results showed a weak negative ICD band in 
300−370 nm range (Figure 7, Inset), its intensity non-
linearly increasing with the ratio r[4]/[poly dG - poly dC]. 
Both, decrease of the DNA CD band and the weak ICD band 
in 300−370 nm range are characteristic for the intercalation 
of phenanthridine into ds-polynucleotide.[34] Intriguingly, 
with alternating polynucleotide poly (dGdC)2 at the same 
pH (Figure 8, left), the observed change < 300 nm was 
opposite (increase, attributed to the contribution of 
intrinsic CD of 4), and no ICD bands were visible. The only 
difference between homo-poly dG - poly dC and alternating 
- poly (dGdC)2 is distribution of amino groups of guanine 
within DNA minor groove, whereby in latter DNA amino 
groups sterically occupy both sides of the groove and 
strongly hinder insertion of small molecule.[31] 
 Further, a pronounced decrease of the band at 262 
nm was also observed for poly A - poly U (Figure 8, right), 
accompanied by a hypsochromic shift of 2 nm, which also 
cannot be attributed to the positive CD band of 4. However, 
in this case no ICD bands were observed in 300−370 nm 
range, suggesting that decrease of RNA CD bands is not due 
to intercalation but more likely due to disproportionation 
of ds-RNA into ss-RNA strands induced by ss-RNA-preferred 
binding of 4 (in agreement with destabilization of ds-RNA in 
thermal denaturation experiments, Table 1). 
 The dipeptide 4 contains modified tyrosine 
susceptible to the photoinduced deamination,[23,25] that 
gives rise to QMs, which again can alkylate DNA or RNA.[26] 
To preliminary test the photochemical reactivity for 
dipeptide 4 with DNA/RNA, dipeptide 4 was irradiated 
(λ=300 nm) in the presence of polynucleotides, followed by 
recording CD spectra (Figures 6−8, r = 0.7 irradiated). Since 
300 nm irradiation is not absorbed by polynucleotide, the 
changes in the CD spectra indicate that photochemical 
reactions take place and affect the polynucleotide chirality. 
It is plausible that irradiation gives rise to the photo-
induced alkylation of DNA,[26] but further experiments are 
needed for full characterization of photochemical products. 
 
CONCLUSION 
We synthesized dipeptide 4 containing two unnatural 
amino acids composed of modified and photochemically 
reactive tyrosine, and phenanthridine. Thermal denatu-
 
Figure 7. CD spectra of poly dG- poly dC (c = 3.0×10−5 mol 
dm−3) in cacodylate buffered aqueous solution (I = 0.05 mol 
dm−3, at pH 5.0) in the presence of different ratio r[4]/[poly 
dG- poly dC]; Inset: dependence of the induced CD signal at 
330 nm on r[4]/[poly dG - poly dC]. 
        
Figure 8. CD spectra of poly (dGdC)2 (left) and poly A - poly U (right) (c = 3.0×10−5 mol dm−3) in cacodylate buffered aqueous 
solution (I = 0.05 mol dm−3) at pH 5.0 in the presence of different ratio r[4]/[polynucleotide]. 
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ration experiments indicated different effects to polynuc-
leotides at pH 5.0 and 7.0, depending on the phenan-
thridine moiety being protonated or not. At pH 5.0, di-
peptide 4 thermally stabilized DNA double helices, and 
destabilized ds-RNA. However, fluorescence titrations with 
all polynucleotides at both pH values gave similar binding 
affinity (log Ka ≈ 5), indicating nonselective binding. 
Nevertheless, changes in the CD spectra suggest different 
modes of binding to polynucleotides, most likely the 
intercalation to poly dG- poly dC or non-specific binding to 
other DNA polynucleotides. On the other hand, binding of 
4 probably induces dissociation of ds-RNA into ss-RNA 
strands due to preferred binding to ss-RNA. Thus, 4 is 
among very rare small molecules that stabilize ds-DNA but 
destabilize ds-RNA. Preliminary photochemical experi-
ments aimed toward formation of reactive QMs and their 
reaction with DNA/RNA revealed structural changes in 
polynucleotide CD spectra, supporting further studies of 
photo-induced reactions of 4 and its analogues. Under-
standing and controlling binding modes of novel dipep-
tides, particularly photoreactive species, to different DNA 
or RNA sequences is essential for the rational design of next 
generation of peptidoids, either as potential drugs, or 
analytical reagents applicable in biology or medicine. 
 
EXPERIMENTAL 
General 
1H and 13C NMR spectra were recorded on a Bruker AV- 300, 
or 600 MHz. The NMR spectra were taken in CD3OD at rt 
using TMS as a reference. HRMS were obtained on an 
Applied Biosystems 4800 Plus MALDI TOF/TOF instrument 
(AB, Foster City, CA). Analytical thin layer chromatography 
was performed on Polygram® SILG/UV254 (Machery-Nagel) 
plates. Chemicals for the synthesis were purchased from 
the usual suppliers, whereas solvents for the synthesis and 
chromatographic separations were purified by distillation, 
or used as received (p.a. grade). Silica gel (0.05–0.2 mm) 
was used for chromatographic purifications. Precursor 
molecules 1-Me[11,36] and 2[25] were prepared according to 
the published procedures. Methyl ester deprotection of 1-
Me and characterization of 1 is given in the SI. 
 
Boc-Phen-Tyr[CH2N(CH3)2]-OBn (3) 
Prior to the reaction, amino acid 1, TFA×2 HBTU, and HOBT 
were dried over night in a desiccator over P2O5. A round 
bottom flask (50 mL) equipped with a septum and under N2 
atmosphere was charged with a solution of 1 (30 mg, 0.08 
mmol), HBTU (30 mg, 0.08 mmol) and HOBT (10 mg, 0.08 
mmol) in dry CH3CN. By use of a syringe triethylamine (TEA) 
(40 μL, 0.32 mmol) was added and the reaction mixture was 
stirred 30 min. A solution of TFA×2 (40 mg, 0.08 mmol) in 
dry CH3CN was added dropvise. The reaction mixture was 
stirred at rt over night. The solvent was removed on a 
rotary evaporator and the oily residue chromatographed 
on a column of silica gel using CH3OH/CH2Cl2 (20→100% 
CH3OH) to afford the pure product (11 mg, 20 %) in the 
form of oil. 
1H NMR (CD3OD, 600 MHz) δ/ppm: 8.63 (t, J = 8.4 Hz, 2H), 
8.11 (s, 1H), 8.00 (d, J = 7.8 Hz, 1H), 7.79 (dd, J = 1.5, 8.6 Hz, 
1H), 7.71 (t, J = 7.4 Hz, 1H), 7.65 (t, J = 8.4 Hz, 1H), 7.32−7.26 
(m, 3H), 7.21−7.16 (m, 2H), 7.07−7.01 (m, 2H), 6.74 (d, J = 
9.0, Hz, 1H), 4.95 (s, 2H), 4.68 (d, J = 7.0 Hz, 1H), 4.45 (dd, J 
= 5.8, 9.0 Hz, 1H), 3.98 (s, 2H), 3.28−3.22 (m, 1H), 3.08−3.01 
(m, 1H), 3.01−2.96 (m, 3H), 2.93 (dd, J = 8.0, 14.0 Hz, 1H), 
2.62 (s, 6H), 1.28 (s, 9H); 13C NMR (CD3OD, 75 MHz) δ/ppm: 
160.6 (s, 1C), 144.0 (s, 1C), 138.6 (s, 1C), 138.5 (s, 1C), 134.0 
(d, 1C), 132.7 (s, 1C), 131.3 (d, 1C), 130.8 (d, 1C), 130.7 (d, 
1C), 129.8 (d, 1C), 129.5 (d, 1C), 129.34 (d, 1C), 129.29 (d, 
1C), 129.1 (d, 1C), 128.5 (d, 1C), 128.1 (s, 1C), 128.0 (d, 1C), 
127.9 (d, 1C), 127.0 (s, 1C), 123.7 (d, 1C), 123.4 (d, 1C), 
116.6 (d, 1C), 67.8 (t, 1C), 62.1 (t, 1C), 56.9 (d, 1C), 55.5 (d, 
1C), 44.6 (q, 2C), 37.7 (t, 1C), 28.6 (q, 3C); HRMS (MALDI-
TOF) m/z [M+H]+ calculated for C41H46N4O6 691.3496; 
observed 691.3483. 
 
HCl×Phen×HCl-Tyr[CH2N(CH3)2×HCl]-OBn (4) 
Dipeptide 3 Boc-Phen-Tyr[CH2N(CH3)2]-OBn (6 mg, 0.01 
mmol) was dissolved in HCl/ EtOAc (1 mL). The reaction 
mixture was stirred over night at rt. The solvent was 
removed on vacuum and the residue washed with ether to 
afford the pure product in the form of oil (7 mg, 99 %). 
1H NMR (CD3OD, 300 MHz) δ/ppm: 9.10−8.86 (m, 2H), 
8.76−8.59 (m, 1H), 8.24 (s, 2H), 8.02 (s, 2H), 7.41−7.05 (m, 
7H), 6.88−6.74 (m, 1H), 5.08−4.91 (m, 2H), 4.75−4.64 (m, 
1H), 4.35−4.16 (m, 2H), 3.76−3.43 (m, 2H), 3.20−2.93 (m, 
2H), 2.81 (d, J = 9.0 Hz, 6H); 13C NMR (CD3OD, 75 MHz) 
δ/ppm: 169.3 (s, 1C), 163.1 (s, 1C), 156.8 (s, 1C), 140.1 (s, 
1C), 136.8 (s, 1C), 135.2 (s, 1C), 134.5 (d, 1C), 134.0 (d, 1C), 
133.9 (d, 1C), 133.7 (d, 1C), 133.6 (d, 1C), 132.6 (d, 1C), 
131.9 (d, 1C), 131.1 (d, 1C), 129.6 (d, 1C), 129.4 (d, 1C), 
129.2 (d, 1C), 129.0 (s, 1C), 125.7 (s, 1C), 125.33 (d, 1C), 
125.29 (d, 1C), 124.9 (d, 1C), 117.6 (s, 1C), 116.6 (d, 1C), 
68.0 (t, 1C), 58.0 (t, 1C), 55.9 (d, 1C), 55.4 (d, 1C), 43.3 (q, 
2C), 38.3 (t, 1C), 37.4 (t, 1C), two carbon signals were not 
observed; HRMS (MALDI-TOF) m/z [M+H]+ calculated for 
C36H40N4O4 591.2971; observed 591.2982. 
 
Polynucleotides 
Polynucleotides were purchased as noted: poly A – poly U, 
poly (dGdC)2, poly dG - poly dC, poly (dAdT)2, calf thymus, ct-
DNA (Sigma). Polynucleotides were dissolved in Na-caco-
dylate buffer, I=0.05 mol dm−3, pH 7.0. The calf thymus ct-
DNA was additionally sonicated and filtered through a 0.45 
mm filter.[29] Polynucleotide concentration was determined 
spectroscopically as the concentration of phosphates. 
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Thermal Denaturation Experiments 
A stock solution of 4 was prepared in mQ H2O (c = 1.0×10−3 
mol dm−3 or c = 1.43×10−3 mol dm−3), whereas the stock 
solutions of polynucleotides were prepared in aqueous 
cacodylate buffer (pH = 7.0, I = 0.05 mol dm−3) in the 
following concentrations: c(ct-DNA) = 1.46×10−2 mol dm−3, 
c(poly A - poly U) = 5.0×10−3 mol dm−3, c(poly (dAdT)2) = 
1.68×10−3 mol dm−3. The solution of ct-DNA was sonicated 
and filtered (pores 0.45 μm) to assure narrow distribution 
of polynucleotide chain lengths. In the denaturation 
experiments, the polynucleotide solution was diluted in a 
quartz UV-vis cell (with the optical path of 1.0 cm) by 
cacodylate buffer to the concentration of c = 3.0×10−5 mol 
dm−3, and the appropriate amount of the solution of 4 was 
added to reach the desired ratio r ([4]/[polynucleotide]) = 
0.3. The dependence of the absorbance at 260 nm as a 
function of temperature was measured on a Cary 100 Bio 
(Agilent Varian) UV-vis spectrometer. The temperature was 
varied from 25 °C to 98 °C in intervals of 0.5 °C.[37,38] The 
denaturation temperature Tm values are the midpoints of 
the transition curves, determined from the maximum of 
the first derivative.[39] ∆Tm values were calculated by 
subtracting Tm of the free nucleic acid from that of the 
respective complex with ∆Tm values (Eq S1 in the SI) are the 
average of at least two independent measurements and 
the error in ∆Tm is ca. ± 0.5 °C. 
 
Fluorescence Titrations 
For the titration, solution of 4 was diluted in a fluorescence 
cell (3 mL) with cacodylate to reach the concentration of c 
= 2.0×10−6 mol dm−3. Polynucleotide stock solutions were c 
= 5.0×10−3 mol dm−3. The fluorescence spectra were 
measured on a Cary Eclipse (Agilent Technologies) at 25 °C. 
The samples were excited at 330 nm, and the emission was 
recorded in the range 350−600 nm. In the titration with ct-
DNA and poly A - poly U, the excitation slit was set to the 
bandpass of 10 nm, and the emission slit to 20 nm, whereas 
in the titrations with other polynucleotides (poly (dAdT)2, 
poly dG - poly dC and poly (dGdC)2) both slits were set to 
the bandpass of 10 nm. Small aliquots of the solutions of 
polynucleotides were added to the solution of 4 and after 
an incubation time of 2 min, fluorescence spectra were 
taken. Data obtained by fluorescence titrations were 
processed by nonlinear regression analysis according to the 
Scatchard equations (eq. S2 in the SI). 
 
Circular Dichroism Spectroscopy 
Circular dichroism spectra were measured on a Jasco J-815 
spectrometer in quartz cells with the optical path of 1 cm 
at 25 °C. The polynucleotide solutions in cuvette were of c 
= 3.0 × 10−5 mol dm−3 in cacodylate buffer (pH = 7.0 or 5.0 , 
I = 0.05 mol dm−3). Aliquots of the solution of 4 in buffer (c 
= 1.0 × 10−3 mol dm−3) were added into cuvette to reach the 
concentration ratio r[4]/[polynucleotide] = 0.1−0.7. The CD 
spectra were recorded in the wavelength range 220-600 
nm with the scanning rate of 200 nm/min and with 2 
accumulations. 
 
Photochemistry 
The samples containing 4 and polynucleotide in the ratio r 
= 0.7 were irradiated in a Luzchem reactor equipped with 8 
lamps (1 lamp 8 W) with the output at 300 nm over 3 min. 
After the irradiation, CD spectra were measured. 
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